• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

September 21, 2010: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda

Food and Drug Administration
Center for Biologics Evaluation and Research
Vaccines and Related Biological Products Advisory Committee
Teleconference Meeting
NIH – Building 29B/Conference Room C
September 21, 2010
DRAFT AGENDA

Open Session

Presentation of Laboratory of Respiratory & Special Pathogens, Division of Bacterial, Parasitic, & Allergenic Products; Laboratory of Hepatitis Viruses, and Laboratory of Vector Borne Virus Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research

2:00 p.m.
Overview of Research/Site Visit Process, Center Biologics Evaluation and Research (CBER)Carolyn Wilson, Ph.D., FDA
2:10
Overview of Office of Vaccines Research and Review (OVRR), CBERKonstantin Chumakov, Ph.D., FDA
2:20

Overview of Division of Bacterial, Parasitic & Allergenic Products (DBPAP), OVRR

Jay Slater, M.D., FDA
2:30
Overview of Laboratory of Respiratory & Special PathogensDrusilla Burns, Ph.D., FDA
2:55
Q&A 
3:00
Overview of Division of Viral Products (DVP), OVRRJerry Weir, Ph.D., FDA
3:10
Overview Laboratory of Hepatitis VirusesStephen Feinstone, M.D., FDA
3:35
Q&A 
3:40
Overview of Laboratory of Vector Borne Virus DiseasesLewis Markoff, M.D., FDA
4:05
Q&A 
4:10
Open Public Hearing (if no speakers, will move directly to closed session) 
5:10
Closed Session  
6:00
Adjourn Meeting